About Us
We are creating the first IV-administered cell therapy that naturally homes to sites of injury in the brain.
TET Therapeutics is a pre-seed biotech startup developing the first IV-deliverable cell therapy for brain injury repair.
Our approach is based on fetomaternal microchimerism: a validated biological phenomenon in which fetal stem cells cross the blood-brain barrier and home to sites of maternal brain injury. We are engineering this mechanism into a scalable therapeutic platform.
